Ammonium tetrathiomolybdate in the decoppering phase treatment of Wilson's disease with neurological symptoms: A case series.
Oriol De FabreguesJaume ViñasAntoni PalasíManuel QuintanaIgnasi CardonaCristina AugerVíctor VargasPublished in: Brain and behavior (2020)
ATTM could be a good treatment for the initial treatment of WD with neurological symptoms due to its high efficacy, with a lower rate of neurological deterioration than the drugs currently available, despite the potential adverse effects.